A. R. Oladipupo, H. A. B. Coker, C. S. Alaribe, and O. D. Okoko, “Microbial Metabolites and Enzymes Inhibition in Drug Discovery and Development: A Case Study of the Statins, a Class of HMG-CoA Reductase Inhibitors: doi.org/10.26538/tjnpr/v3i4.1”, TJNPR, vol. 3, no. 4, pp. 99–106, Apr. 2019, Accessed: Dec. 28, 2024. [Online]. Available: https://tjnpr.org/index.php/home/article/view/936